EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Differential modulation of adipose tissue insulin resistance by modified traditional Japanese diet and SGLT-2 inhibitor canagliflozin in type 2 diabetes

Eiji Kutoh, Alexandra N Kuto, Rumiko Okada, Nozomi Urushibara

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04573-2 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Eiji Kutoh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, 1-5-8-613 Komatsugawa, Edogawa-Ku, Tokyo, 132-0034, Japan. eijikuto@gmail.com. Hauptthemen laut MEDLINE: Canagliflozin, Diabetes Mellitus, Type 2, Insulin Resistance, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CanagliflozinDiabetes Mellitus, Type 2Insulin ResistanceSodium-Glucose Transporter 2 InhibitorsAdipose TissueHumansMaleMiddle AgedFemaleAgedBlood GlucoseProspective StudiesGlycated HemoglobinInsulinWeight LossJapanEast Asian People

Stichwörter der Autor:innen

Adipose tissue insulin resistance (adipo-IR)Beta-cell functionBody weight changesCanagliflozinSGLT-2 inhibitorTraditional Japanese diet

Substanzen

CanagliflozinSodium-Glucose Transporter 2 InhibitorsBlood GlucoseGlycated HemoglobinInsulin

Autor:innen und Institutionen

  • Biomedical Center, 1-5-8-613 Komatsugawa, Edogawa-Ku, Tokyo, 132-0034, Japan. eijikuto@gmail.com.
  • Division of Diabetes, Department of Internal Medicine, Kumagaya Surgery Hospital, Kumagaya, Japan. eijikuto@gmail.com.
  • Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Gyoda, Japan. eijikuto@gmail.com.
  • Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, Japan. eijikuto@gmail.com.
  • Biomedical Center, 1-5-8-613 Komatsugawa, Edogawa-Ku, Tokyo, 132-0034, Japan.
  • Division of Diabetes, Department of Internal Medicine, Kumagaya Surgery Hospital, Kumagaya, Japan.

Zitieren

APA

Kutoh, E., Kuto, A. N., Okada, R., & Urushibara, N. (2026). Differential modulation of adipose tissue insulin resistance by modified traditional Japanese diet and SGLT-2 inhibitor canagliflozin in type 2 diabetes. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04573-2

Vancouver

Kutoh E, Kuto AN, Okada R, Urushibara N. Differential modulation of adipose tissue insulin resistance by modified traditional Japanese diet and SGLT-2 inhibitor canagliflozin in type 2 diabetes. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04573-2

BibTeX
@article{Kutoh2026,
  author = {Kutoh, Eiji and Kuto, Alexandra N and Okada, Rumiko and Urushibara, Nozomi},
  title = {Differential modulation of adipose tissue insulin resistance by modified traditional Japanese diet and SGLT-2 inhibitor canagliflozin in type 2 diabetes},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04573-2}
}
Kostenlos starten →